Mahindra Lifespace Developers (532313) Q1 25/26 earnings summary

Executive summary

• Q1 FY26 saw strong business momentum, with significant GDV additions, robust leasing in industrial clusters, and a successful rights issue completed during the quarter.

• The company is pursuing a strategy to achieve INR 10,000 crore sales by FY 2030, focusing on premium/mid-premium segments in MMR, Pune, and Bengaluru, and exiting the affordable segment.

• Strategic partnerships, sustainability-led themes, and customer-centric innovation are key pillars for scaling the business 5X over five years.

• Unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, were approved by the Board on July 25, 2025.

• The results reflect the impact of a significant rights issue and are not fully representative of ongoing operations due to the completed contracts method of revenue recognition.

Financial highlights

• Residential pre-sales reached INR 450.49 crore, lower than last year due to fewer launches, while IC revenues grew 16% year-over-year to INR 120 crore.

• EBITDA increased to INR 46 crore from INR 27 crore year-over-year, and PAT rose nearly 4x to INR 51 crore, driven by higher other income and debt optimization.

• Consolidated revenue from operations for Q1 FY26 was ₹3,197 lakhs, up from ₹864 lakhs in Q1 FY25.

• Net debt-to-equity ratio is negative at -0.23, reflecting a strong cash position post-rights issue and debt repayment.

• Operating cash flow was close to INR 200 crore, with land acquisitions at approximately INR 225 crore for the quarter.

Outlook and guidance

• Targeting 25%-30% annual growth, with internal discussions aiming for INR 4,500-5,000 crore in FY 2027, up from INR 2,804 crore in FY 2025.

• Launch plan for FY26 includes major projects in Mumbai, Pune, Bengaluru, and Chennai, with 65% of FY26 sales expected from new launches.

• GDV potential from current and pipeline projects estimated at ~₹41,000 crore, with phased launches planned based on market absorption and regulatory approvals.

• The company notes that results for the quarter are not representative of current operations due to the completed contracts method under Ind AS 115.